Suvretta Capital Management, Llc

13F Holdings History for Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

Symbol: BNTC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001
Latest Disclosed Ownership: 17.8M shares
Security Ownership: 44.1%

Shares, Excluding Options vs Price

Value, Excluding Options

SUVRETTA CAPITAL MANAGEMENT, LLC ownership in Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC)

2025-11-10 - SUVRETTA CAPITAL MANAGEMENT, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 17.8M shares of Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC). This represents 44.1% percent ownership of the company. In their previous filing dated 2025-03-28, SUVRETTA CAPITAL MANAGEMENT, LLC had reported owning 15.6M shares, indicating an increase of 13.7% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
SUVRETTA CAPITAL MANAGEMENT, LLC	44.1%	-11.6%	$249M	17.8M	+2,138,286	+13.7%	$14.03	13D/A	11/7/2025	10 Nov 2025 21:53:47
SUVRETTA CAPITAL MANAGEMENT, LLC	49.9%		$203M	15.6M			$13.01	13D/A	3/26/2025	28 Mar 2025 16:50:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	4.2%		$139M	9.88M			$14.03	Q3 2025
6/30/2025	4.35%		$116M	9.88M			$11.70	Q2 2025
3/31/2025	5.2%	+0.48%	$128M	9.88M	+916,497		$13.01	Q1 2025
12/31/2024	4.19%	+0.06%	$113M	8.96M	+130,956	+1.48%	$12.63	Q4 2024
9/30/2024	2.91%	+2.35%	$81.1M	8.83M	+7,137,763	+422%	$9.19	Q3 2024
6/30/2024	0.48%	+0.46%	$11.8M	1.69M	+1,487,070	+728%	$6.99	Q2 2024
3/31/2024	0.05%		$1.07M	204K			$5.25	Q1 2024
12/31/2023	0.03%		$660K	204K			$3.23	Q4 2023
9/30/2023	0.03%	+0.03%	$617K	204K	+204,220	NEW	$3.02	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.